HCW Biologics Inc. (HCWB)
2.44
-0.07
(-2.79%)
USD |
NASDAQ |
Sep 09, 11:22
HCW Biologics Shareholders Equity (Quarterly) : 7.428M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.428M |
| March 31, 2026 | 5.762M |
| December 31, 2025 | 2.765M |
| September 30, 2025 | -2.107M |
| June 30, 2025 | -0.052M |
| March 31, 2025 | -8.562M |
| December 31, 2024 | -6.770M |
| September 30, 2024 | -9.970M |
| June 30, 2024 | -6.300M |
| March 31, 2024 | 8.741M |
| December 31, 2023 | 13.46M |
| Date | Value |
|---|---|
| September 30, 2023 | 23.87M |
| June 30, 2023 | 28.59M |
| March 31, 2023 | 32.62M |
| December 31, 2022 | 37.43M |
| September 30, 2022 | 42.56M |
| June 30, 2022 | 46.17M |
| March 31, 2022 | 49.40M |
| December 31, 2021 | 51.19M |
| September 30, 2021 | 54.01M |
| June 30, 2021 | 8.864M |
| March 31, 2021 | 11.58M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.77M |
| Total Liabilities (Quarterly) | 19.34M |
| Debt to Equity Ratio | 0.8834 |
| Current Ratio | 0.0611 |
| Net Debt Paydown Yield | 18.28% |